# The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

> **NCT02449161** · PHASE3 · TERMINATED · sponsor: **Guy Waddell** · enrollment: 60 (actual)

## Conditions studied

- Menorrhagia

## Interventions

- **DRUG:** MPA
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02449161
- **Lead sponsor:** Guy Waddell
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Missing fund to continue
- **Last updated:** 2022-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02449161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02449161, "The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02449161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*